# Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist

> **NCT02866838** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 64 (actual)

## Conditions studied

- Intracerebral Hemorrhage

## Interventions

- **DRUG:** Tranexamic acid
- **DRUG:** Saline 0.9%

## Key facts

- **NCT ID:** NCT02866838
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2021-09-30
- **Final completion:** 2022-03-22
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2022-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02866838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02866838, "Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02866838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*